Characterization of Viral Genome Encapsidated in Adeno-associated Recombinant Vectors Produced in Yeast Saccharomyces cerevisiae

• Published in: Molecular biotechnology Vol. 63; no. 2; pp. 156 - 165
• Main Authors: Galli, Alvaro, Iaia, Ilenia, Milella, Maria Serena, Cipriani, Filippo, Della Latta, Veronica, Giacca, Mauro, Zentilin, Lorena, Cervelli, Tiziana
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.02.2021; Springer Nature B.V
• Subjects: Baculovirus; Biochemistry; Biological Techniques; Biotechnology; Cell Biology; Chemistry; Chemistry and Materials Science; Clinical trials; Commercialization; Deoxyribonucleic acid; DNA; Encapsidation; Gene therapy; Genomes; Human Genetics; Original Paper; Protein Science; Rep gene; Saccharomyces cerevisiae; Yeast; Yeasts; rAAV; Adeno-associated virus; Encapsidation; Viral genome; Gene therapy; Saccharomyces cerevisiae
• ISSN: 1073-6085; 1559-0305
• DOI: 10.1007/s12033-020-00294-4

Adeno-associated virus (AAV) is a small, non-enveloped virus used as vector in gene therapy, mainly produced in human cells and in baculovirus systems. Intense studies on these platforms led to the production of vectors with titers between 10 3 and 10 5 viral genomes (vg) per cells. In spite of this, vector yields need to be improved to satisfy the high product demands of clinical trials and future commercialization. Our studies and those of other groups have explored the possibility to exploit the yeast Saccharomyces cerevisiae to produce rAAV. We previously demonstrated that yeast supports AAV genome replication and capsid assembly. The purpose of this study was to evaluate the quality of the encapsidated AAV DNA. Here, we report the construction of a yeast strain expressing Rep68/40 from an integrated copy of the Rep gene under the control of the yeast constitutive ADH promoter and Capsid proteins from the Cap gene under the control of an inducible GAL promoter. Our results indicate that a portion of AAV particles generated by this system contains encapsidated AAV DNA. However, the majority of encapsidated DNA consists of fragmented regions of the transgene cassette, with ITRs being the most represented sequences. Altogether, these data indicate that, in yeast, encapsidation occurs with low efficiency and that rAAVs resemble pseudo-vectors that are present in clinical-grade rAAV preparations.